What is Aegis Thymosin Alpha 1 Complex?
This peptide formulation combines thymic peptides with metabolic and immunomodulatory compounds: Thymosin Alpha 1, Thymalin, Ursolic Acid, RG3 Ginsenoside, and an AMPK Activator. Together, these agents synergize across immune restoration, anti-inflammation, metabolic regulation, anti-cancer activity, and antisenescence pathways.
Aegis Thymosin Alpha 1 3.2mg | Thymalin 2.5mg | Ursolic Acid 25mg | RG3 Ginsenoside 50mg | AMPK Activator 50mg
EXTENDED PROTOCOL
Thymosin Alpha 1:
Stimulates CD4+/CD8+ T-cell differentiation and Th1 immunity. Enhances dendritic cell function and MHC class I expression, suppresses NF-κB and chronic inflammation.
Thymalin:
Regulates gene expression via chromatin remodeling. Normalizes immune cell populations and rejuvenates thymic activity. Anti-senescence via telomerase support and inflammatory downregulation.
Ursolic Acid:
Activates AMPK, enhances mitochondrial function and fat oxidation. Inhibits NF-κB and STAT3 signaling (anti-inflammatory, anti-cancer). Reduces muscle wasting and supports metabolic regeneration.
RG3 Ginsenoside:
Inhibits NF-κB and COX-2 (inflammatory suppression). Blocks VEGF and MMP pathways to reduce tumor angiogenesis. Activates Nrf2 antioxidant defense and induces apoptosis in damaged cells.
AMPK Activator:
Increases PGC-1α and mitochondrial biogenesis. Induces autophagy via ULK1 activation. Suppresses mTOR and NF-κB (aging and inflammation dampening).
Clinical Applications:
- Immune Restoration – Post-viral fatigue, immune suppression, and immunosenescence recovery.
- Autoimmune Balancing – Normalizes overactive immune responses and reduces chronic inflammation.
- Senescence Reversal / Longevity Protocols – Supports telomerase activity and reduces aging markers.
- Metabolic & Fat Loss Support – Enhances fat oxidation and improves insulin sensitivity.
- Muscle Maintenance & Recovery – Prevents muscle wasting during illness or aging.
- Oncology Support (Adjunctive Use) – Reduces tumor angiogenesis and induces apoptosis in damaged cells.
Dosage & Administration:
50 IU – 100 IU per injection via subcutaneous (SC) or intramuscular (IM) route. Frequency: 3–7 times per week depending on immune status and therapeutic goals.
Cycle Duration:
Duration: 4–8 weeks, extendable for chronic immune modulation or longevity support. Standard cycle is repeatable depending on clinical need.
Monitoring Parameters:
Recommended to track inflammatory markers (CRP, IL-6), immune function (CD4/CD8 ratio), and metabolic markers (HbA1c, fasting insulin) for optimization.
Can be integrated with regenerative medicine protocols (stem cells, exosomes, NK cells) for synergistic effects on immune rejuvenation and systemic repair.
Synergy Map – Overlapping Targets:
- Immune Rejuvenation – Enhance thymopoiesis, CD4+/CD8+ balance, and immune activation
- Inflammation Control – Suppress NF-κB, IL-6, TNFα pathways
- Anti-Senescence – Inhibit mTOR, activate telomerase, reduce senescence markers
- Cancer Suppression – Apoptosis induction, immune surveillance, angiogenesis inhibition
- Metabolic Enhancement – Increase fat oxidation, insulin sensitivity, mitochondrial function
- Autophagy & Repair – Activate ULK1, support detoxification and damaged cell recycling
